Zealand Pharma A/S | ZEAL - Ebit

Aktienkurs
265.10
Täglich Wechseln
2.30 0.88%
Monatlich
-32.04%
Jährlich
-54.72%
Q1 Prognose
222.73




Ebit Veränderung Datum
Akebia Therapeutics USD 13.51M 27.82M 2025-03
Alaunos Therapeutics USD -1.19M 148K 2025-09
Avita Medical AUD -10.39M 1.72M 2025-12
Dianthus Therapeutics USD -40.29M 5.36M 2025-09
Ionis Pharmaceuticals USD -215M 54.82M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Moderna USD -857M 597M 2025-12
Organon & Co USD 388M 28M 2025-09
Revvity USD 145.83M 47.49M 2025-12
Tectonic Therapeutic USD -22.33M 4.03M 2025-06
Tilray USD -20.01M 9.34M 2025-09
Viatris USD -157.5M 392M 2025-12
Xeris Pharmaceuticals USD 7.89M 2.46M 2025-09